Empowered Funds LLC Takes Position in Chemed Corporation $CHE

Empowered Funds LLC acquired a new stake in Chemed Corporation (NYSE:CHE) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 2,060 shares of the company’s stock, valued at approximately $959,000.

Several other institutional investors and hedge funds have also recently modified their holdings of CHE. Commonwealth Equity Services LLC grew its stake in Chemed by 3.1% during the 4th quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock valued at $314,000 after purchasing an additional 22 shares during the last quarter. Cim LLC raised its holdings in shares of Chemed by 1.1% during the 3rd quarter. Cim LLC now owns 2,139 shares of the company’s stock worth $958,000 after acquiring an additional 24 shares during the period. Eukles Asset Management increased its position in shares of Chemed by 0.4% during the fourth quarter. Eukles Asset Management now owns 6,056 shares of the company’s stock valued at $2,591,000 after acquiring an additional 25 shares during the last quarter. MassMutual Private Wealth & Trust FSB grew its stake in shares of Chemed by 65.3% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company’s stock worth $38,000 after acquiring an additional 32 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its stake in Chemed by 9.4% in the first quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company’s stock worth $153,000 after acquiring an additional 35 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Price Performance

Shares of NYSE:CHE opened at $520.82 on Friday. The company has a market capitalization of $6.81 billion, a PE ratio of 26.16, a price-to-earnings-growth ratio of 1.99 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. The stock has a fifty day moving average of $516.70 and a 200-day moving average of $451.82. Chemed Corporation has a one year low of $365.20 and a one year high of $557.00.

Chemed (NYSE:CHE) last announced its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.60 by $0.46. The company had revenue of $673.25 million for the quarter, compared to the consensus estimate of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company’s revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the business earned $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, equities analysts anticipate that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th were issued a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a yield of 0.5%. This is an increase from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date was Monday, August 17th. Chemed’s dividend payout ratio is 14.06%.

Analyst Ratings Changes

Several brokerages recently weighed in on CHE. Royal Bank Of Canada increased their price target on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a report on Thursday, July 30th. Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Bank of America reissued a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Oppenheimer boosted their price objective on Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a report on Friday, July 31st. Finally, Wall Street Zen raised Chemed from a “hold” rating to a “strong-buy” rating in a research report on Saturday, August 1st. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $530.75.

Insider Buying and Selling

In other news, Director Patrick P. Grace sold 190 shares of Chemed stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $532.00, for a total value of $101,080.00. Following the transaction, the director directly owned 3,533 shares in the company, valued at approximately $1,879,556. The trade was a 5.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $541.16, for a total value of $1,082,320.00. Following the completion of the sale, the chief executive officer directly owned 70,418 shares of the company’s stock, valued at $38,107,404.88. This represents a 2.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 6,537 shares of company stock worth $3,406,014 over the last ninety days. 3.33% of the stock is currently owned by corporate insiders.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.